<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>Whitepaper</title>
    <link>https://qservegroup.com/whitepaper</link>
    <description>This is a section</description>
    <language>en</language>
    <pubDate>Thu, 30 Jul 2026 13:06:52 GMT</pubDate>
    <dc:date>2026-07-30T13:06:52Z</dc:date>
    <dc:language>en</dc:language>
    <item>
      <title>Human Factors in Medical Device Submissions</title>
      <link>https://qservegroup.com/whitepaper/human-factors-in-medical-device-submissions</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://qservegroup.com/whitepaper/human-factors-in-medical-device-submissions" title="" class="hs-featured-image-link"&gt; &lt;img src="https://qservegroup.com/hubfs/Website%20Banner-Jul-30-2026-01-06-41-9065-PM.png" alt="Human Factors in Medical Device Submissions" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;p&gt;Two FDA guidance documents now govern human factors evidence for a medical device marketing submission. The 2016 guidance explains how to run the human factors engineering (HFE) process; the 2026 guidance sorts every submission into one of three HF Submission Categories, each carrying a different documentation burden. Read separately, the two invite confusion. Read as one system, they describe a single body of evidence viewed from three angles: submission, quality management system (QMS), and inspection.&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://qservegroup.com/whitepaper/human-factors-in-medical-device-submissions" title="" class="hs-featured-image-link"&gt; &lt;img src="https://qservegroup.com/hubfs/Website%20Banner-Jul-30-2026-01-06-41-9065-PM.png" alt="Human Factors in Medical Device Submissions" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;p&gt;Two FDA guidance documents now govern human factors evidence for a medical device marketing submission. The 2016 guidance explains how to run the human factors engineering (HFE) process; the 2026 guidance sorts every submission into one of three HF Submission Categories, each carrying a different documentation burden. Read separately, the two invite confusion. Read as one system, they describe a single body of evidence viewed from three angles: submission, quality management system (QMS), and inspection.&lt;/p&gt;  
&lt;img src="https://track-eu1.hubspot.com/__ptq.gif?a=145725324&amp;amp;k=14&amp;amp;r=https%3A%2F%2Fqservegroup.com%2Fwhitepaper%2Fhuman-factors-in-medical-device-submissions&amp;amp;bu=https%253A%252F%252Fqservegroup.com%252Fwhitepaper&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>function-Senior Consultant</category>
      <pubDate>Thu, 30 Jul 2026 13:06:52 GMT</pubDate>
      <guid>https://qservegroup.com/whitepaper/human-factors-in-medical-device-submissions</guid>
      <dc:date>2026-07-30T13:06:52Z</dc:date>
      <dc:creator>Tim Joiner</dc:creator>
    </item>
  </channel>
</rss>
